Developers of the Sinopharm vaccine say an interim analysis has found it to be nearly 80 per cent effective against Covid-19. Photo: EPA-EFE
China’s Sinopharm reports strong interim results for its Covid-19 vaccine
- Few details were released in the announcement but the company is seeking conditional listing from Chinese regulator
- United Arab Emirates has already reported good results from its interim analysis of late-stage trials
Topic |
Coronavirus pandemic
Developers of the Sinopharm vaccine say an interim analysis has found it to be nearly 80 per cent effective against Covid-19. Photo: EPA-EFE